The company announced the acquisition of $1 million in Bitcoin and other cryptocurrencies on Dec. 20, triggering a 10% drop in its stock.
Another publicly traded company has joined the growing ranks of firms incorporating cryptocurrencies into their treasury strategies.
On Dec. 20, biopharmaceutical company Quantum BioPharma (QNTM) disclosed the purchase of $1 million worth of Bitcoin (BTC) and other cryptocurrencies. The company’s shares on the Nasdaq were down nearly 10% following the announcement.
QNTM performance on the Nasdaq. Source: Google Finance
